Upadacitinib is effective in inducing clinical response and remission and is generally well tolerated in patients with perianal Crohn’s disease, a real-world study shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/upadacitinib-effective-perianal-crohns-real-world-data-show-2026a1000ejg?src=rss
Author :
Publish date : 2026-05-08 12:00:00
Copyright for syndicated content belongs to the linked Source.
